Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Argus Life Sciences is a contract development and manufacturing organization (CDMO) based in India that specializes in the research, development, and production of pharmaceutical intermediates and fine chemicals. The company provides customized synthesis services and process optimization to support global pharmaceutical and biotechnology firms in their drug development efforts. Their core expertise lies in complex chemical synthesis, including the production of high-purity intermediates for active pharmaceutical ingredients (APIs). By operating modern R&D and manufacturing facilities, Argus Life Sciences facilitates the transition of chemical processes from lab-scale to commercial production. The company serves a diverse client base across the life sciences industry, focusing on quality compliance and timely delivery of specialty chemical building blocks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Argus Life Sciences.